Abstract:The increasing breadth and depth of resolution in biological and clinical data, including ‐omics and real‐world data, requires advanced analytical techniques like artificial intelligence (AI) and machine learning (ML) to fully appreciate the impact of multi‐dimensional population variability in intrinsic and extrinsic factors on disease progression and treatment outcomes. Integration of advanced data analytics in Quantitative Pharmacology is crucial for drug‐disease knowledge management, enabling precise, efficient and inclusive drug development and utilization – an application we refer to as Model‐Informed Precision Medicine. AI/ML enables characterization of the molecular and clinical sources of heterogeneity in disease trajectory, advancing endpoint qualification and biomarker discovery, and informing patient enrichment for Proof‐of‐Concept studies as well as trial designs for efficient evidence generation incorporating digital twins and virtual control arms. Explainable ML methods are valuable in elucidating predictors of efficacy and safety of pharmacological treatments, thereby informing response monitoring and risk mitigation strategies. In oncology, emerging opportunities exist for development of the next generation of disease models via ML‐assisted joint longitudinal modeling of high‐dimensional biomarker data such as circulating tumor DNA and radiomics profiles as predictors of survival outcomes. Finally, mining real world data leveraging ML algorithms enables understanding of the impact of exclusion criteria on clinical outcomes, thereby informing rational design of appropriately inclusive clinical trials through data‐driven broadening of eligibility criteria. Herein, we provide an overview of the aforementioned contexts of use of ML in drug‐disease modeling based on examples across multiple therapeutic areas including neurology, rare diseases, autoimmune diseases, oncology and immuno‐oncology.

Toward trustable use of machine learning models of variant effects in the clinic

The promise of machine learning in predicting treatment outcomes in psychiatry

Statistical Thinking, Machine Learning

Factors influencing clinician and patient interaction with machine learning-based risk prediction models: a systematic review

Causal Inference and Counterfactual Prediction in Machine Learning for Actionable Healthcare

A giant with feet of clay: on the validity of the data that feed machine learning in medicine

The challenges of using machine learning models in psychiatric research and clinical practice

Reliable machine learning models in genomic medicine using conformal prediction

Machine learning model to predict risk assessment of a child inheriting a genetic disorder

A review of model evaluation metrics for machine learning in genetics and genomics

Clinical Applications of Machine Learning

Machine Learning Strategies for Improved Phenotype Prediction in Underrepresented Populations

Machine learning in medicine: Addressing ethical challenges

Classification of genetic variants using machine learning

Risk estimation and risk prediction using machine-learning methods

Machine learning in precision diabetes care and cardiovascular risk prediction

Machine Learning in Modeling Disease Trajectory and Treatment Outcomes: An Emerging Enabler for Model‐Informed Precision Medicine

An Empirical Characterization of Fair Machine Learning For Clinical Risk Prediction

Stronger Baseline Models -- A Key Requirement for Aligning Machine Learning Research with Clinical Utility

Learning to Predict with Supporting Evidence: Applications to Clinical Risk Prediction

Machine learning models' assessment: trust and performance